4/A//SEC Filing
Czuczman Myron 4/A
Accession 0001213900-24-074517
CIK 0001851484other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:05 PM ET
Size
6.1 KB
Accession
0001213900-24-074517
Insider Transaction Report
Form 4/AAmended
Czuczman Myron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+1,400,000→ 1,400,000 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (1,400,000 underlying)
Footnotes (2)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.
- [F2]This Form 4 has been amended to correct the amount of option shares held by the Reporting Person.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001817716
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 4:05 PM ET
- Size
- 6.1 KB